Name (Synonyms) | Correlation |
---|
There is one clinical trial.
A controlled trial of the drug tranexamic acid (TXA) in outpatients who were recently diagnosed with COVID-19. It is hypothesized that TXA will reduce the infectivity and virulence of the virus.
Description: Admission to hospital for COVID-19 treatment
Measure: Hospitalization Time: Randomization to 7 days after randomization